Therapeutic Implications of the Cancer Stem Cell Hypothesis
To access this article, please choose from the options below
MFC is a member of the paid advisory board of Oncomed Pharmaceuticals, Inc, and owns stock options in the company.
PII: S1053-4296(08)00078-7
doi:10.1016/j.semradonc.2008.11.002
© 2009 Elsevier Inc. All rights reserved.
